Cannagistics (CNGT) 10-Q/A 17 Feb 21 2021 Q1 Quarterly report (amended) Financial data

Cover

Cover - shares	3 Months Ended
	Oct. 31, 2020	Dec. 14, 2020
Cover [Abstract]
Document Type	10-Q/A
Amendment Flag	true
Amendment Description	Amend report
Document Period End Date	Oct. 31, 2020
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--07-31
Entity Registrant Name	Cannagistics Inc.
Entity Central Index Key	0001304741
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		172,789,105

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Oct. 31, 2020	Jul. 31, 2020
CURRENT ASSETS:
Cash and cash equivalents	$ 3,299	$ 685
Right-to-use asset	23,033	23,033
Related party receivables, less allowance for doubtful accounts of $1,015,234	0	0
TOTAL CURRENT ASSETS	26,332	23,718
Right-to-use asset, net of current portion	26,635	31,442
Security deposits	(3,634)	(3,634)
TOTAL OTHER ASSETS	30,269	35,076
TOTAL ASSETS	56,601	58,794
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	747,229	607,961
Lease liability, current portion	18,505	18,505
Promissory notes	170,000	170,000
Convertible notes payable, net of discount of $122,863 and $58,087 October 31, 2020 and July 31, 2020, respectively	2,393,706	2,426,254
Derivative liabilities	755,223	205,796
Common stock payable	0	24,998
Related party payables	386,404	388,094
TOTAL CURRENT LIABILITIES	4,471,067	3,841,608
LONG-TERM LIABILITIES
Lease liability, net of current portion	33,752	38,559
TOTAL LONG-TERM LIABILITIES	33,752	38,559
LIABILITIES OF DISCONTINUED OPERATIONS	837,778	839,646
TOTAL LIABILITIES	5,342,597	4,719,813
STOCKHOLDERS' DEFICIT:
Preferred Stock; $0.001 par value; 20,000,000 shares authorized, 10,000,000 and 8,000,000 shares issued and outstanding as of October 31, 2020 and July 31, 2020, respectively	10,000	10,000
Common stock; $0.001 par value; 500,000,000 and 250,000,000 shares authorized as of October 31, 2020 and July 31, 2020, respectively; 158,789,105 and 105,099,277 outstanding and issued as of October 31, 2020 and July 31, 2020, respectively	158,789	105,099
Additional paid-in capital	9,098,230	8,490,720
Treasury stock	(45,000)	(45,000)
Accumulated deficit	(14,508,015)	(13,221,838)
TOTAL STOCKHOLDERS' DEFICIT	(5,285,995)	(4,661,019)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT	$ 56,601	$ 58,794

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Oct. 31, 2020	Jul. 31, 2020
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	250,000,000
Common stock, shares issued	158,789,105	105,099,277
Common stock, shares outstanding	158,789,105	105,099,277
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, Shares authorized	20,000,000	20,000,000
Preferred Stock, shares issued	10,000,000	8,000,000
Related party receivables , less allowance for doubful accounts	$ 1,015,234
Convertible notes payable, net of discount	$ 122,863	$ 58,087

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Operating expenses
General and administrative expenses	$ 37,575	$ 5,892
Rent	7,486	10,676
Consulting	28,500	28,600
Professional fees	82,884
Total operating expenses	156,445	92,552
Loss from operations	(156,445)	(92,552)
Interest income	21,759	21,759
Interest expense	(147,634)	(98,901)
Penalty on convertible note payable	(25,000)
Loss on derivative liabilities	(936,075)
Change in fair value of derivative liabilities	(42,782)
Total other expense	(1,129,732)	(77,142)
Loss from continuing operations	(1,286,177)	(169,694)
Discontinued operations, including loss on disposal		(119,081)
Net loss	$ (1,286,177)	$ (288,775)
Net loss per common share: basic and diluted	$ (0.01)	$ 0
Basic and diluted weighted average common shares outstanding	102,834,619	93,117,423

Consolidated Shareholders Equit

Consolidated Shareholders Equity (Unaudited) - USD ($)	Common Stock	Preferred Stock C	Preferred Stock D	Additional Paid-In Capital	Treasury Stock	Noncontrolling Interest	Accumulated Deficit	Total
Beginning balance, shares at Jul. 31, 2019	93,118,077		8,000,000
Beginning balance, amount at Jul. 31, 2019	$ 93,030		$ 8,000	$ 7,382,579	$ (45,000)		$ (10,539,338)	$ (3,100,729)
Shares issued for conversion of convertible debt, shares
Shares issued for conversion of convertible debt, value
Shares issued for settlement of payables, shares
Shares issued for settlement of payables, value
Foreign currency translation adjustment							1,351	1,351
Net loss							(288,775)	(288,775)
Ending balance, shares at Oct. 31, 2019	93,118,077		8,000,000
Ending balance, amount at Oct. 31, 2019	$ 93,030		$ 8,000	7,382,579	(45,000)		(10,826,762)	(3,388,153)
Beginning balance, shares at Jul. 31, 2020	105,099,277		10,000,000
Beginning balance, amount at Jul. 31, 2020	$ 105,099		$ 10,000	8,490,720	(45,000)		(13,221,838)	(4,661,019)
Shares issued for conversion of convertible debt, shares	51,190,000
Shares issued for conversion of convertible debt, value	$ 51,190			585,012				636,202
Shares issued for settlement of payables, shares	2,499,828
Shares issued for settlement of payables, value	$ 2,500			22,498				24,998
Foreign currency translation adjustment
Net loss							(1,286,177)	(1,286,177)
Ending balance, shares at Oct. 31, 2020	158,789,105		10,000,000
Ending balance, amount at Oct. 31, 2020	$ 158,789		$ 10,000	$ 9,098,230	$ (45,000)		$ (14,508,015)	$ (5,285,995)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Cash Flows from Operating Activities
Net loss	$ (1,286,177)	$ (288,775)
Loss from discontinued operations		119,081
Adjustments to reconcile net loss to net cash provided by operating activities:
Foreign currency adjustment		1,351
Settlement Fees on conversion of stock	13,000
Penalty on convertible note payable	25,000
Loss on derivative liabilities	452,944
Change in fair value of derivative liabilities	525,913
Amortization of debt discount	40,224
Changes in assets and liabilities
Accounts receivable and other receivables		24,135
Prepaid expense		(5,267)
Accounts payable and accrued expenses	139,278	159,536
Net cash used in operating activities of continuing operations	(89,818)	10,061
Net cash used in operating activities discontinued operations	(1,868)	(119,081)
Net cash used in operating activities	(91,686)	(109,020)
Cash Flows from Investing Activities
(Increase) decrease in restricted cash		(52)
Net cash used in investing activities		(52)
Cash Flows from Financing Activities
Proceeds from convertible notes, net of amortization	96,000
Proceeds from line of credit		276,037
Proceeds from loans		71,800
Proceeds from related parties	32,900
Payments on loans		(12,176)
Payments on line of credit		245,787
Payments to related parties	34,600
Net cash provided by financing activities	94,300	111,713
Net increase in cash	2,614	2,641
Cash, beginning of period	685	630
Cash, end of period	3,299	3,271
Cash paid for interest		5,227
Cash paid for tax
Non-cash investing and financing transactions
Original issuance discount on convertible notes payable	9,000	11,000
Conversion of notes payable, fees, and derivative liabilities	$ 636,202

Organization and Description of

Organization and Description of Business	3 Months Ended
	Oct. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Organization	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS Organization and Description of Business Cannagistics, Inc. (Formerly FIGO Ventures, Inc., formerly Precious Investments, Inc.) (‘The Company’) was incorporated under the laws of the State of Nevada on May 26, 2004. The Company was an Exploration Stage Company with the principal business being the acquisition and exploration of resource properties. The Company had allowed its charter with the state of Nevada to be revoked by the Secretary of State for failure to file the required annual lists and pay the required annual fees. Its last known officers and directors reflected in the records of the Secretary of State were unresponsive or stated they were no longer involved with the Company. The purported replacement officers and directors were unresponsive. On September 14, 2012, NPNC Management, LLC filed a petition in the Eighth Judicial District Court in Clark County, Nevada and was appointed custodian of the Company on January 15, 2012. On October 24, 2012, the interim board authorized the sale of 55,000,000 (2,200,000 split adjusted) shares of common stock for $6,000 to NPNC Management, LLC, in a private placement transaction exempt from the Securities Act of 1933, as amended, pursuant to section 4(2) thereof and the rules and regulations promulgated there under. On March 1, 2017, the Company then entered into a joint venture agreement with Eddeb Management (“Eddeb”). The purpose of the joint venture is to build a fund for the purpose of trading in precious gems, notably, colored diamonds. On November 16, 2017, the Company entered into an Agreement of Merger and Plan of Reorganization (the “Merger Agreement”) with American Freight Xchange, Inc., a privately held New York corporation (“American Freight”), and Shipzooka Acquisition Corp. (“Shipzooka Sub”), a newly formed wholly owned Nevada subsidiary of Precious Investments, Inc. In connection with the closing of this merger transaction, Shipzooka Sub merged with and into American Freight (the “Merger”) on December 5, 2017, with the filing of Articles of Merger with the Nevada Secretary of State and Certificate of Merger with the New York Division of Corporations. The transaction resulted in the Company acquiring Subsidiary by the exchange of all of the outstanding shares of Subsidiary for 1,000,000 newly issued Series C Preferred shares of stock, $0.001 par value (the “Preferred Stock”) of Parent which have conversion and voting rights of 72.5 votes for each share, representing approximately 90.2% of the voting rights For accounting purposes, the transaction was treated as a reverse merger since the acquired entity now forms the basis for operations and the transaction resulted in a change in control, with the acquired company electing to become the successor issuer for reporting purposes. The accompanying financial statements have been prepared to reflect the assets, liabilities and operations of American Freight Xchange, Inc. exclusive of Precious Investments, Inc since all predecessor operations were discontinued. As part of the transaction, amounts due to former officers were forgiven, with the balances recorded as Contributed Capital. For equity purposes, accumulated deficit shown are those American Freight Xchange, Inc. Shipzooka Acquisition Corp. is a dormant corporation. On July 23, 2018 the Company amended the name of its subsidiary, KRG Logistics, Inc., to Global3pl, Inc. (an Ontario corporation). On September 4, 2018 the Company incorporated Cannagistics, Inc., in the province of Ontario, Canada. This is intended to be a possible new line of business for the Company but is dormant at this time. On April 17, 2019, we filed Articles of Merger with the Secretary of State of Nevada in order to effectuate a merger with our wholly owned subsidiary, Cannagistics, Inc. Shareholder approval was not required under Section 92A.180 of the Nevada Revised Statutes. As part of the merger, our board of directors authorized a change in our name to “Cannagistics, Inc.” and our Articles of Incorporation have been amended to reflect this name change. On September 26, 2019, the Board of Directors approved the registered spinout of its Global3pl, Inc., (a New York corporation) (“Global3pl”) subsidiary. Global3pl is to be a logistics technology provider, along with the American Freight Xchange and UrbanX Platforms that have been under development by the Company. The Board of Directors also declared a stock dividend for all shareholders, with a record date of October 10, 2019. For every 50 shares of common stock of the Company, all shareholders of record on the record date will receive one share of common stock in Global3pl. Global3pl will also file a registration statement as part of its raise of capital to complete the development of American Freight Xchange, a North American freight broker-driven 3pl network to handle the management of long haul LTL (less than truckload), and specialty freight (white glove) services and Urbanx, a North American network of rush-messenger local trucking services for forward and reverse last mile delivery (including white glove service). However, the Company has carefully reconsidered its position with respect to the previously announced and subsequently amended spin off of Global3pl, Inc., (a New York corporation). Due to the current situation resulting from the COVID-19 pandemic and especially in light of the development of the supply chain management strategy of the Company, it has been determined that the finalization of the development of the Global3pl platform will be integral and serve as the “engine” for the supply chain management of the Company. Therefore, at this time the “spin-off” has been indefinitely postponed until such time and it may make sense from a business standpoint. The Company has not issued any shares in the Global3pl, Inc (New York) subsidiary. Effective October 1, 2019, the Company suspended operations of its subsidiary Global3pl, Inc., formerly known as KRG Logistics, Inc., (an Ontario corporation), suspended future operations related to the operations in Mississauga, Ontario. It is in the process of collecting accounts receivables still due and working on a plan to pay its payables. It has entered into an agreement with 10451029 Canada Inc., d/b/a Reliable Logistics, for the assignment and of the assets of Global3pl, Inc., (an Ontario Corporation). The transaction was completed on November 6, 2019. The Company anticipates formally liquidating and dissolving the subsidiary in the next fiscal Quarter. This is a separate corporation from Global3pl, Inc. (A New York corporation). Current Projects in Development Global3PL Inc. (NY) During the past 24 months, Global3PL Inc. (a New York Corporation) has consulted with logistics and technology experts to design and begin the development of a best-of-breed, first-of-kind information technology system. To date, about eighteen (18) months’ worth of custom coding by our contractor has been completed with an expectation of an additional 2-3 months of work still required for it to be ready for testing. Upon completion, it is intended that clients shall be able to login to the system to communicate and transact business with the Company in real-time, as it relates to aspects of the client’s supply chain. This can include the tracking of inbound raw material from various vendors, the manufacturing schedule of finished goods, inventory tracking of raw materials and finished goods, international compliance documentation, and the contacting and tracking of the shipping of the finished goods to their delivery destination(s). Though the Company has high expectations for the functionality of the new system, it does not make any assurances that the system will be completed, shall work as planned if completed, nor be embraced by potential clients as intended. Therefore Global3pl, Inc. (NY) will be a logistics subsidiary serving the just-in-time inventory & distribution industry, as well as the special and general commodities sector of the North American freight industry. “Just-in-time” is an industry word for delivery a product or other item to an end user right before it is needed. It is used in place of an end user storing a large quantity of inventory. Shippers will be able to sync to our system for a real-time 360 views of their product shipments, including, location updates, verification, and risk mitigation. The customer will be able to Geolocation GPS tracking of freight movement; create automated notifications with consolidated and automated notifications, payments, and reporting. The Shipper interface will also allow customers to push or post freight orders. The software system will also allow for lead-generation, data analysis, collaboration among shippers, Automated billing and collections, and automated payments. The SAAS-based platform ecosystem will fully integrate all aspects of the Company’s operations, from receiving raw materials for clients, through product manufacturing, document compliance, distribution, and shelf-life batch tracking. It had been expected to be operational in the third or fourth quarter of 2020, however due to economic conditions from the COVID-19 Pandemic, and the need for funding related to this Offering, to complete the process, we have been delayed and hope to be operational by the end of the second quarter of 2021. The SaaS-based platform ecosystem will fully integrate all aspects of the Cannagistics operations, from receiving raw materials for clients, through product manufacturing, document compliance, distribution, and shelf-life batch tracking. It is intended to operate with four separate brands or identities, that being Global3pl, AFX (the acronym for American Freight Xchange) UrbanX and Cannagistics. Our targeted client markets (OTC, pharmaceutical, nutraceutical, cosmetics, and Hemp/CBD-related products) are heavily regulated, and highly fragmented from state to state, and country to country. Every country has their own certified product standards; such as the FDA in the U.S. Target client markets require batch product tracking throughout shelf life and GMP certified standards in manufacturing. There is currently, we believe, a lack of seamless automation across the supply chain. Our solution offers a fully automated and scalable service for end to end information, manufacturing, sales, and tracking. We believe the benefits achieved from our logistics services for clients are as follows: § Ability to track products from ingredient stage all the way to sale; § Provides 24/7 visibility; § Expands collaboration; § Provide a single point of access: § Incorporates big data and client behavior statistics; § Reduces redundancy; § Increases productivity; § Offers a subscription based model; and § Capable of supporting multiple client usage. GMP Certified Facilities We have plans to develop a GMP certified biotech lab in Malta with a fundamental skill in initially the cosmetic and then potentially the medicinal, nutraceutical and cannabis/hemp/CBD industries. Our plan is to have this Malta lab cater to customers in the EU. We also plan to potentially have other facilities that will cover our target customers in the US, Canada and Columbia, potentially located in Baton Rouge, Toronto and Bogotá, respectively. If we are successful in fully developing such capabilities we intend to seek out and employ a team of a multidisciplinary professionals in the pharmaceutical, nutraceutical and over the counter industries, and utilize complex supply chain and logistics management, unique technology and intellectual property. Cannagistics’ Lab’s purpose is to add value and offer a progress proposal to the Malta medicinal cannabis industry, based on its interest to support, educate, take advantage of and focus on the development of potentially breakthrough medicinal cannabis products with different therapeutic uses in patients around the world to whom science and traditional medicine simply could not reach. Such products will be subject to testing and certification from various governmental agencies, which may be a difficult expensive and time-consuming process. Our vision and knowledge will potentially focus on GMP biopharmaceutical cannabis-based medicines, - with the highest standards starting from the raw material - for multiple applications in patients, using latest technology, ancestral knowledge, scientific studies, with an exceptional team of research and development following the strictest standards and good distribution practices for export and national use. We have no manufacturing plant or GMP facilities at the present time. As we continue our search to find suitable facilities, we believe that we will need to have the following areas for the production process, which will implement the safety protocols required for the project to be developed. § Area of receipt: Area of the property that has been destined for the receipt of the raw material and supplies that arrives for the manufacturing process. § Raw material area: Warehouse equipped with the security measures required for the storage of the raw material. § Production and manufacturing area: Sector where the manufacturing process will be carried out in which the transforming plant will be in order to obtain the final product. § Reagents and supplies area: Warehouse equipped with the security measures required for the storage of reagents and supplies. § Solid waste area: Sector destined for the storage of solid waste produced during the manufacturing process. § Finished product area: Warehouse equipped with the security measures required for the storage of the finished product. § Dispatch area: Sector from where the process of dispatch and delivery of the finished product to its final recipient will take place § Administrative area: Sector of the factory where administrative, accounting and security activities will be developed. Competition The Global Supply Chain management area has many different entities, all competing. Some are very large. However, our model is significantly different from most of the providers already operating. To be successful in the global supply chain management area, a company must be involved in planning the function of the entire process, from start to finish, or end to end. We intend to concentrate our model on the cannabis, nutraceutical, pharmaceutical and cosmetic areas. We believe this makes our approach unique and distinguishable at this time. There is no guarantee that a larger, more fully funded, company will determine to seek to gain access to the same business. Intellectual Property Our Global3pl SAAS Platform is a proprietary software developed by the Company. The SaaS-based platform ecosystem will fully integrate all aspects of the Cannagistics operations, from receiving raw materials for clients, through product manufacturing, document compliance, distribution, and shelf-life batch tracking.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Principals	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of consolidation The consolidated financial statements include the accounts of Cannagistics, Inc. and its wholly owned subsidiaries American Freight Xchange, Inc and Global3pl, Inc. (Ontario), formerly known as KRG Logistics, Inc. All significant inter-company transactions and balances have been eliminated. Basis of Presentation We have summarized our most significant accounting policies for the fiscal period ended July 31, 2020. Unaudited Consolidated Interim Financial Statements These unaudited condensed consolidated interim financial statements have been prepared on the same basis as the annual financial statement and should be read in conjunction with those annual financial statements filed on Form 10-K for the year ended July 31, 2020. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results for a full year or for any future period. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cannagistics, Inc., and Subsidiaries Notes to Financial Statements October 31, 2020 COVID-19 Pandemic Update In March 2020, the World Health Organization declared a global health pandemic related to the outbreak of a novel coronavirus. The COVID-19 pandemic adversely affected the company's financial performance in the third and fourth quarters of fiscal year 2020 and could have an impact throughout fiscal year 2021. In response to the COVID-19 pandemic, government health officials have recommended and mandated precautions to mitigate the spread of the virus, including shelter-in-place orders, prohibitions on public gatherings and other similar measures. As a result, the company and certain of the company's customers and suppliers temporarily closed locations beginning late in the second quarter of fiscal year 2020, continuing into the third quarter of fiscal year 2020. There is uncertainty around the duration and breadth of the COVID-19 pandemic, as well as the impact it will have on the company's operations, supply chain and demand for its products. As a result, the ultimate impact on the company's business, financial condition or operating results cannot be reasonably estimated at this time. Income Taxes The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company reviews the terms of convertible loans, equity instruments and other financing arrangements to determine whether there are embedded derivative instruments, including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. Also, in connection with the issuance of financing instruments, the Company may issue freestanding options or warrants to employees and non-employees in connection with consulting or other services. These options or warrants may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. Derivative financial instruments are initially measured at their fair value. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at fair value and then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. To the extent that the initial fair values of the freestanding and/or bifurcated derivative instrument liabilities exceed the total proceeds received an immediate charge to income is recognized in order to initially record the derivative instrument liabilities at their fair value. The discount from the face value of the convertible debt instruments resulting from allocating some or all of the proceeds to the derivative instruments, together with the stated rate of interest on the instrument, is amortized over the life of the instrument through periodic charges to income, using the effective interest method. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period. If reclassification is required, the fair value of the derivative instrument, as of the determination date, is reclassified. Any previous charges or credits to income for changes in the Cannagistics, Inc., and Subsidiaries Notes to Financial Statements October 31, 2020 fair value of the derivative instrument are not reversed. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Fair value of financial instruments The Company’s financial instruments consist of its liabilities. The carrying amount of payables and the loan payable – related party approximate fair value because of the short-term nature of these items. The promissory notes, and convertible notes payables are measured at amortized cost using the effective interest method, which approximates fair value due to the relationship between the interest rate on long-term debt and the Company’s incremental risk adjusted borrowing rate. Fair value is defined under FASB ASC Topic 820 as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for an asset or liability in an orderly transaction between participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard describes a fair value hierarchy based on the levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value. The levels are as follows: · Level 1 - Quoted prices in active markets for identical assets or liabilities · Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or corroborated by observable market data for substantially the full term of the assets or liabilities · Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the value of the assets or liabilities The following is a listing of the Company’s liabilities required to be measured at fair value on a recurring basis and where they are classified within the fair value hierarchy as of October 31, 2020 and July 31, 2020: October 31, 2020 Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 755,223 $ 755,223 July 31, 2020 Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 205,796 $ 205,796 Cannagistics, Inc., and Subsidiaries Notes to Financial Statements October 31, 2020 Accounts receivable and allowance for doubtful accounts Accounts receivable are stated at the amount management expects to collect. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. As of October 31, 2020, and 2019 the allowance for doubtful accounts was $0 and $0, respectively. Revenue Recognition The Company recognizes revenue related to transaction from its third-party logistics sales by performing the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to arrangements that meet the definition of a contract under Topic 606, including when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company evaluates the goods or services promised within each contract related performance obligation and assesses whether each promised good or service is distinct. The Company recognizes as revenue, the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Amounts invoiced or collected in advance of product delivery or providing services are recorded as unearned revenue or customer deposits. The company accrues for sales returns, bad debts, and other allowances based on its historical experience In May 2014, the FASB issued ASU 2014-09 “Revenue from Contracts with Customers” (Topic 606) which establishes revenue recognition standards. ASU 2014-09 was effective for annual reporting periods beginning after December 15,2017. We adopted ASU 2014-09 effective August 1, 2018. ASU 2014-09 has not had a significant effect on the Company’s financial position and results of operations. Foreign Currency FASB ASC Topic 830, Foreign Currency Matters (formerly FASB Statement No. 52, Foreign Currency Translation) provides accounting guidance for transactions denominated in a foreign currency, and for operations undertaken in a foreign currency environment. To prepare consolidated financial statements, an entity translates all functional currency financial statements into a single reporting currency. The same applies if an entity uses different currencies for reporting purposes and for its functional currency. The company reports its currency in US dollars. Stock-Based Compensation The Company measures expenses associated with all employee stock-based compensation awards using a fair-value method and record such expense in our consolidated financial statements on a straight-line basis over the requisite service period. Leases In February 2016, FASB issued ASU-2016-02 (Topic 842) “Leases”, provides accounting guidance for leases, recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018. Recent Accounting Pronouncements Financial Instruments (Topic 326): Measurement of Credit Losses on Financial Instruments

Going Concern

Going Concern	3 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Going Concern	NOTE 3 – GOING CONCERN Management does not expect existing cash as of October 31, 2020 to be sufficient to fund the Company’s operations for at least twelve months from the issuance date of these October 31, 2020 financial statements. These financial statements have been prepared on a going concern basis which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As of October 31, 2020, the Company has an accumulated deficit of $14,508,015, and has not yet generated material revenue from operations, and will require additional funds to maintain its operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern within one year after the consolidated financial statements are issued. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. The Company intends to finance operating costs over the next twelve months through its existing financial resources and we may also raise additional capital through equity offerings, debt financings, collaborations and/or licensing arrangements. If adequate funds are not available on acceptable terms, we may be required to delay, reduce the scope of, or curtail, our operations. The accompanying consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Discontinued Operations

Discontinued Operations	3 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Discontinued Operations	NOTE 4 – DISCONTINUED OPERATIONS October 31, July 31, 2020 2020 Accounts payable $ 460,262 $ 462,130 Royal Bank line of credit 289,242 289,242 Unearned revenue 14,833 14,833 Accrued liabilities 64,663 64,663 Custom duties & GST payable 6,019 6,01 9 HST 2,759 2,759 Liabilities of discontinued operations $ 837,778 $ 839,646

Promissory Notes

Promissory Notes	3 Months Ended
	Oct. 31, 2020
Debt Disclosure [Abstract]
Promissory Notes	NOTE 5 – PROMISSORY NOTES Promissory notes payable as of October 31, 2020 and July 31, 2020 consisted of the following: Description October 31, 2020 July 31, 2020 Note payable dated March 8, 2018, matured March 8, 2019, bearing interest at 10% per annum. $ 30,000 $ 30,000 Note payable dated July 18, 2018, matured July 18, 2019, bearing interest at 8% per annum. $ 135,000 $ 135,000 Note payable dated February 4, 2020, matured February 4, 2021, bearing interest at 18% per annum. $ 5,000 $ 5,000 Total $ 170,000 $ 170,000 Less current portion of long-term debt $ 170,000 $ 170,000 Total long-term debt — — Interest expense for the three months ended October 31, 2020 and 2019 was $3,705 and $4,285, respectively.

Convertible Debt

Convertible Debt	3 Months Ended
	Oct. 31, 2020
Convertible Debt [Abstract]
Convertible Debt	NOTE 6 - CONVERTIBLE DEBT Convertible debt as of October 31, 2020 and July 31, 2020 consisted of the following: Description October 31, 2020 July 31, 2020 Convertible note agreement dated November 1, 2013 in the amount of $30,000 payable and due on demand bearing interest at 12% per annum. Principal and accrued interest is convertible at $.002250 per share. $ 11,041 $ 11,041 Convertible note agreement dated February 20, 2018 in the amount of $1,034,000 payable and due on demand bearing interest at 10% per annum. Principal and accrued interest is convertible at $.028712 per share. $ 1,034,000 $ 1,034,000 Convertible note agreement dated March 13, 2019 in the amount of $800,000 payable and due on March 20, 2020 bearing interest at 24% per annum. $ 800,000 $ 800,000 Convertible note agreement dated June 28, 2019 in the amount of $300,000 payable and due on June 28, 2020 bearing interest at 20% per annum. $ 300,000 $ 300,000 Convertible note agreement dated August 6, 2019 in the amount of $31,500 payable and due on August 6, 2020 bearing interest at 20% per annum. $ 31,500 $ 31,500 Convertible note agreement dated August 19, 2019 in the amount of $3,800 payable and due on August 19, 2020 bearing interest at 24% per annum. $ 3,800 $ 3,800 Convertible note agreement dated September 4, 2019 in the amount of $36,500 payable and due on September 4, 2020 bearing interest at 20% per annum. $ 36,500 $ 36,500 Convertible note agreement dated December 4, 2019 in the amount of $95,000 payable and due on December 4, 2020 bearing interest at 12% per annum. $ 95,000 $ 95,000 Convertible note agreement dated February 10, 2020 in the amount of $15,000 payable at February 10, 2021 bearing interest at 12% per annum.. $ 15,000 $ 15,000 Convertible note agreement dated February 21, 2020 in the amount of $47,500 payable at February 21, 2021 bearing interest at 12% per annum. $ 47,500 $ 47,500 Convertible note agreement dated February 28, 2020 in the amount of $67.500 payable at February 28, 2021 bearing interest at 12% per annum. $ 21,341 $ 67,500 Convertible note agreement dated April 15, 2020 in the amount of $31,500 payable at April 15, 2021 bearing interest at 10% per annum, net of discount. $ 15,887 $ 31,500 Convertible note agreement dated September 29, 2020 in the amount of $34.000 payable and due on September 29, 2021 bearing interest at 12% per annum. $ 34,000 $ — Convertible note agreement dated October 9, 2020 in the amount of $33,000 payable and due on October 9, 2021 bearing interest at 12% per annum. $ 33,000 $ — Convertible note agreement dated October 19, 2020 in the amount of $38.000 payable and due on October 19, 2020 bearing interest at 12% per annum. $ 38,000 $ — Convertible notes, net of discount $ 2,516.569 $ 2,475,341 The Company recognized $0 of debt discount accretion expense on the above notes. Interest expense related to these notes for the three months ended October 31, 2020 and 2019 was $100,457 and $92,016. Derivative liabilities Certain of the Company’s convertible notes are convertible into a variable number of shares of common stock for which there is not a floor to the number of common stock shares the Company might be required to issue. Based on the requirements of ASC 815 Derivatives and Hedging, the conversion feature represented an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results each reporting period. The Company uses the Black-Scholes option pricing model for the valuation of its derivative liabilities as further discussed below. There are no material differences between using the Black-Scholes option pricing model for these estimates as compared to the Binomial Lattice model. During the three months ended October 31, 2020, three new notes with a variable-rate conversion feature were issued. The Company valued the conversion features on the date of issuance resulting in initial liabilities totaling $548,944. Since the fair value of the derivative was in excess of the proceeds received, a full discount to the convertible notes payable and a day one loss on derivative liabilities of $452,944 was recorded during the three months ended October 31, 2020. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion prices ranging from $0.0029 to $0.0058, the closing stock price of the Company's common stock on the dates of valuation ranging from $0.008 to $0.034, an expected dividend yield of 0%, expected volatilities ranging from 219%-251%, risk-free interest rate ranging from 0.12% to 0.15%, and expected terms of one year. As of July 31, 2020, the Company had existing derivative liabilities of $205,796 related to two convertible notes. During the three months ended October 31, 2020, $97,772 in principle of these convertible notes along with fees of $13,000 were converted into 51,190,000 shares of common stock. At each conversion date, the Company recalculated the value of the derivative liability associated with the convertible note recording a gain (loss) in connection with the change in fair market value. In addition, the pro-rata portion of the derivative liability as compared to the portion of the convertible note converted was reclassed to additional paid-in capital. During the three months ended October 31, 2020, the Company recorded $525,430 to additional paid-in capital for the relief of the derivative liabilities. The derivative liabilities were revalued using the Black-Scholes option pricing model with the following assumptions: conversion prices ranging from $0.0018 to $0.007, the closing stock price of the Company's common stock on the dates of valuation ranging from $0.006 to $0.034, an expected dividend yield of 0%, expected volatility ranging from 215% to 262%, risk-free interest rates ranging from 0.12% to 0.15%, and expected terms ranging from 0.09 to 0.48 years. On October 31, 2020, the derivative liabilities on these convertible notes were revalued at $755,223 resulting in a loss of $525,913 for the three months ended October 31, 2020 related to the change in fair value of the derivative liabilities. The derivative liabilities were revalued using the Black-Scholes option pricing model with the following assumptions: conversion prices ranging from $0.0020 to $0.0029, the closing stock price of the Company's common stock on the date of valuation of $0.015, an expected dividend yield of 0%, expected volatility of 269%, risk-free interest rate of 0.13%, and an expected term ranging from 0.08 to 0.97 years. The Company amortizes the discounts over the term of the convertible promissory notes using the straight-line method which is similar to the effective interest method. During the three months ended October 31, 2020, the Company amortized $40,224 to interest expense. As of October 31, 2020, discounts of $122,363 remained for which will be amortized through October 2021.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Oct. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 7 – RELATED PARTY TRANSACTIONS A shareholder of the Company has paid certain expenses of the Company. These amounts are reflected as a loan payable to related party. The shareholder advanced $0 and $19,490 during the three months ended October 31, 2020 and 2019, respectively. As of October 31, 2020, and 2019, there were $386,404 and $375,344 due to related parties, and a shareholder, respectively. The Company has consulting agreements with two of its shareholders to provide management and financial services that commenced on December 1, 2017. For the three months ended October 31, 2020 and 2019 consulting fees paid were $48,484 and $44,769 respectively. The consulting fees are included as part of professional fees on the Company’s consolidated statements of operations. The Company on February 20, 2018 entered into a related party (that being Recommerce Group, Inc. and our former President and current Vice-President of Corporate Finance and a Director, is a principal in Recommerce Group, Inc.) note receivable in the amount of $1,034,000. The Company made an additional advance in the amount of $175,000 that is non-interest bearing. The note is payable and due on demand and bears interest at the rate of 10%. A total of $153,217 has been applied as payments against this Note. Interest expense in the amount of $21,759 and $26,062 for the three months ended October 31, 2020 and 2019, respectively, has been recorded in the financial statements .

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	3 Months Ended
	Oct. 31, 2020
Equity [Abstract]
Stockholders' Equity	NOTE 8 – STOCKHOLDERS’ EQUITY (DEFICIT) The Company is authorized to issue 500,000,000 shares of its $0.001 par value common stock and 10,000,000 shares of Preferred stock. As of October 31, 2020, and July 31, 2020, there were 93,118,077 shares, of common stock outstanding. There were 10,000,000 shares of Series D Preferred stock outstanding as of October 31, 2020 and 8,000,000 shares of Series D Preferred Stock outstanding as of July 31, 2020. On November 1, 2017, we effected a one-for- four reverse stock split. All share and per share information has been retroactively adjusted to reflect the stock split. On November 7, 2017, the Company designated 1,000,000 shares of Preferred Stock as Series C Preferred stock, par value $0.001 per share (the “Series C Preferred Stock”). Each share of Series C Preferred Stock is convertible into 72.5 common shares and has voting rights based on this ratio. As of January 31, 2018, there were 1,000,000 shares of Preferred C shares issued and outstanding. On May 15, 2019, the 1,000,000 shares were converted to 72,500,000 shares of common stock. On April 29, 2019, the Company designated 10,000,000 shares of Preferred Stock as Series D Preferred stock, par value $0.001 per share (the “Series D Preferred Stock”). Each share of Series D Preferred Stock is convertible into 72.5 common shares and has voting rights based on this ratio. There were 10,000,000 shares of Series D Preferred stock outstanding as of October 31, 2020 and 8,000,000 shares of Series D Preferred Stock outstanding as of July 31, 2019. On May 6, 2020, the Company filed an Offering Statement under Regulation A on form 1-A for a Tier II Offering of 43,000,000 shares .

Warrant

Warrant	3 Months Ended
	Oct. 31, 2020
Other Liabilities Disclosure [Abstract]
Warrant	NOTE 9 – WARRANT On April 15, 2020, the Company issued a five-year Common Stock Purchase Warrant in connection with a $31,500 convertible promissory note. The warrant is convertible into 437,500 shares of the Company’s common stock at $.12 per share. On April 23, 2020, the Company issued a three-year Common Stock Purchase Warrant in connection with a $75,000 investment in the Company’s common stock. The warrant has a conversion price of $.15 per share of the Company’s common stock.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Oct. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 10 – COMMITMENTS AND CONTINGENCIES Litigations, Claims and Assessments The Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise that may harm its business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results. Operating Leases The Company in February 2019 assumed a lease agreement for a facility site and entered into a lease agreement for office space. The facility site lease has a term of twenty-three months expiring on December 31, 2020 and the office space lease has a five-year term and begins April 1, 2019 and ends March 31, 2024. Effective October 1, 2019, the Company suspended operations of its subsidiary Global3pl, Inc., (an Ontario corporation, formerly known as KRG Logistics, Inc.), suspended future operations related to the operations in Mississauga, Ontario. It is in the process of collecting accounts receivables still due and working on a plan to pay its payables. It has entered into an agreement with 10451029 Canada Inc., d/b/a Reliable Logistics, for the assignment and of the assets of Global3pl, Inc., (an Ontario Corporation). The transaction has not yet been completed. The Company on July 31, 2019 entered into a lease agreement for additional office space. The lease has a commencement date of June 1, 2019 and has a lease term of five years expiring on May 31, 2024. Future minimum lease payments, as set forth in the lease, are below: Year Amount 2019-2020 $ 3,363 2020-2021 $ 22,737 2021-2022 $ 23,415 2022-2023 $ 24,122 2023-2024 $ 14,314

Subsequent Events

Subsequent Events	3 Months Ended
	Oct. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 11 – SUBSEQUENT EVENTS Management of the Company has evaluated the subsequent events that have occurred through the date of the report and determined that the following subsequent events require disclosure: On November 16, 2020, the Company issued 6,000,000 shares of its common stock at $0.0011 for the conversion of notes payable. On November 23, 2020, the Company issued 8,000,000 shares of its common stock at $0.0018 for the conversion of notes payable. On December 2, 2020 the Company established NOVI Biosciences, Inc. (a New York corporation as a new wholly owned subsidiary. On December 4, 2020, the Company issued 5,307,100 shares of its common stock at $0.0022 for the conversion of notes payable.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Principles of consolidation	The consolidated financial statements include the accounts of Cannagistics, Inc. and its wholly owned subsidiaries American Freight Xchange, Inc and Global3pl, Inc. (Ontario), formerly known as KRG Logistics, Inc. All significant inter-company transactions and balances have been eliminated.
Basis of presentation	We have summarized our most significant accounting policies for the fiscal period ended July 31, 2020. Unaudited Consolidated Interim Financial Statements These unaudited condensed consolidated interim financial statements have been prepared on the same basis as the annual financial statement and should be read in conjunction with those annual financial statements filed on Form 10-K for the year ended July 31, 2020. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results for a full year or for any future period.
Accounts Receivable and allowance for doubtful accounts	Accounts receivable are stated at the amount management expects to collect. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. As of October 31, 2020, and 2019 the allowance for doubtful accounts was $0 and $0, respectively.
Use of Estimates	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
COVID-19 Pandemic Update	In March 2020, the World Health Organization declared a global health pandemic related to the outbreak of a novel coronavirus. The COVID-19 pandemic adversely affected the company's financial performance in the third and fourth quarters of fiscal year 2020 and could have an impact throughout fiscal year 2021. In response to the COVID-19 pandemic, government health officials have recommended and mandated precautions to mitigate the spread of the virus, including shelter-in-place orders, prohibitions on public gatherings and other similar measures. As a result, the company and certain of the company's customers and suppliers temporarily closed locations beginning late in the second quarter of fiscal year 2020, continuing into the third quarter of fiscal year 2020. There is uncertainty around the duration and breadth of the COVID-19 pandemic, as well as the impact it will have on the company's operations, supply chain and demand for its products. As a result, the ultimate impact on the company's business, financial condition or operating results cannot be reasonably estimated at this time.
Income taxes	The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.
Derivative Financial Instruments	The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company reviews the terms of convertible loans, equity instruments and other financing arrangements to determine whether there are embedded derivative instruments, including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. Also, in connection with the issuance of financing instruments, the Company may issue freestanding options or warrants to employees and non-employees in connection with consulting or other services. These options or warrants may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. Derivative financial instruments are initially measured at their fair value. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at fair value and then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. To the extent that the initial fair values of the freestanding and/or bifurcated derivative instrument liabilities exceed the total proceeds received an immediate charge to income is recognized in order to initially record the derivative instrument liabilities at their fair value. The discount from the face value of the convertible debt instruments resulting from allocating some or all of the proceeds to the derivative instruments, together with the stated rate of interest on the instrument, is amortized over the life of the instrument through periodic charges to income, using the effective interest method. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period. If reclassification is required, the fair value of the derivative instrument, as of the determination date, is reclassified. Any previous charges or credits to income for changes in the fair value of the derivative instrument are not reversed. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
Fair value of financial instruments	The Company’s financial instruments consist of its liabilities. The carrying amount of payables and the loan payable – related party approximate fair value because of the short-term nature of these items. The promissory notes, and convertible notes payables are measured at amortized cost using the effective interest method, which approximates fair value due to the relationship between the interest rate on long-term debt and the Company’s incremental risk adjusted borrowing rate. Fair value is defined under FASB ASC Topic 820 as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for an asset or liability in an orderly transaction between participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard describes a fair value hierarchy based on the levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value. The levels are as follows: · Level 1 - Quoted prices in active markets for identical assets or liabilities · Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or corroborated by observable market data for substantially the full term of the assets or liabilities · Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the value of the assets or liabilities The following is a listing of the Company’s liabilities required to be measured at fair value on a recurring basis and where they are classified within the fair value hierarchy as of October 31, 2020 and July 31, 2020: October 31, 2020 Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 755,223 $ 755,223 July 31, 2020 Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 205,796 $ 205,796
Foreign currency	FASB ASC Topic 830, Foreign Currency Matters (formerly FASB Statement No. 52, Foreign Currency Translation) provides accounting guidance for transactions denominated in a foreign currency, and for operations undertaken in a foreign currency environment. To prepare consolidated financial statements, an entity translates all functional currency financial statements into a single reporting currency. The same applies if an entity uses different currencies for reporting purposes and for its functional currency. The company reports its currency in US dollars.
Stock-Based Compensation	The Company measures expenses associated with all employee stock-based compensation awards using a fair-value method and record such expense in our consolidated financial statements on a straight-line basis over the requisite service period.
Revenue recognition	The Company recognizes revenue related to transaction from its third-party logistics sales by performing the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to arrangements that meet the definition of a contract under Topic 606, including when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company evaluates the goods or services promised within each contract related performance obligation and assesses whether each promised good or service is distinct. The Company recognizes as revenue, the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Amounts invoiced or collected in advance of product delivery or providing services are recorded as unearned revenue or customer deposits. The company accrues for sales returns, bad debts, and other allowances based on its historical experience In May 2014, the FASB issued ASU 2014-09 “Revenue from Contracts with Customers” (Topic 606) which establishes revenue recognition standards. ASU 2014-09 was effective for annual reporting periods beginning after December 15,2017. We adopted ASU 2014-09 effective August 1, 2018. ASU 2014-09 has not had a significant effect on the Company’s financial position and results of operations.
Leases	In February 2016, FASB issued ASU-2016-02 (Topic 842) “Leases”, provides accounting guidance for leases, recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018.
Recent Accounting Pronouncements	Financial Instruments (Topic 326): Measurement of Credit Losses on Financial Instruments

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended	12 Months Ended
	Oct. 31, 2020	Jul. 31, 2020
Accounting Policies [Abstract]
Derivative Liabilities	October 31, 2020 Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 755,223 $ 755,223	July 31, 2020 Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 205,796 $ 205,796

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Liabilities of discontinued operations	October 31, July 31, 2020 2020 Accounts payable $ 460,262 $ 462,130 Royal Bank line of credit 289,242 289,242 Unearned revenue 14,833 14,833 Accrued liabilities 64,663 64,663 Custom duties & GST payable 6,019 6,01 9 HST 2,759 2,759 Liabilities of discontinued operations $ 837,778 $ 839,646

Promissory Notes (Tables)

Promissory Notes (Tables)	3 Months Ended
	Oct. 31, 2020
Debt Disclosure [Abstract]
Schedule of Promissory Notes	Description October 31, 2020 July 31, 2020 Note payable dated March 8, 2018, matured March 8, 2019, bearing interest at 10% per annum. $ 30,000 $ 30,000 Note payable dated July 18, 2018, matured July 18, 2019, bearing interest at 8% per annum. $ 135,000 $ 135,000 Note payable dated February 4, 2020, matured February 4, 2021, bearing interest at 18% per annum. $ 5,000 $ 5,000 Total $ 170,000 $ 170,000 Less current portion of long-term debt $ 170,000 $ 170,000 Total long-term debt — —

Convertible Debt (Tables)

Convertible Debt (Tables)	3 Months Ended
	Oct. 31, 2020
Convertible Subordinated Debt [Abstract]
Summary of Convertible Debt	NOTE 6 - CONVERTIBLE DEBT Convertible debt as of October 31, 2020 and July 31, 2020 consisted of the following: Description October 31, 2020 July 31, 2020 Convertible note agreement dated November 1, 2013 in the amount of $30,000 payable and due on demand bearing interest at 12% per annum. Principal and accrued interest is convertible at $.002250 per share. $ 11,041 $ 11,041 Convertible note agreement dated February 20, 2018 in the amount of $1,034,000 payable and due on demand bearing interest at 10% per annum. Principal and accrued interest is convertible at $.028712 per share. $ 1,034,000 $ 1,034,000 Convertible note agreement dated March 13, 2019 in the amount of $800,000 payable and due on March 20, 2020 bearing interest at 24% per annum. $ 800,000 $ 800,000 Convertible note agreement dated June 28, 2019 in the amount of $300,000 payable and due on June 28, 2020 bearing interest at 20% per annum. $ 300,000 $ 300,000 Convertible note agreement dated August 6, 2019 in the amount of $31,500 payable and due on August 6, 2020 bearing interest at 20% per annum. $ 31,500 $ 31,500 Convertible note agreement dated August 19, 2019 in the amount of $3,800 payable and due on August 19, 2020 bearing interest at 24% per annum. $ 3,800 $ 3,800 Convertible note agreement dated September 4, 2019 in the amount of $36,500 payable and due on September 4, 2020 bearing interest at 20% per annum. $ 36,500 $ 36,500 Convertible note agreement dated December 4, 2019 in the amount of $95,000 payable and due on December 4, 2020 bearing interest at 12% per annum. $ 95,000 $ 95,000 Convertible note agreement dated February 10, 2020 in the amount of $15,000 payable at February 10, 2021 bearing interest at 12% per annum.. $ 15,000 $ 15,000 Convertible note agreement dated February 21, 2020 in the amount of $47,500 payable at February 21, 2021 bearing interest at 12% per annum. $ 47,500 $ 47,500 Convertible note agreement dated February 28, 2020 in the amount of $67.500 payable at February 28, 2021 bearing interest at 12% per annum. $ 21,341 $ 67,500 Convertible note agreement dated April 15, 2020 in the amount of $31,500 payable at April 15, 2021 bearing interest at 10% per annum, net of discount. $ 15,887 $ 31,500 Convertible note agreement dated September 29, 2020 in the amount of $34.000 payable and due on September 29, 2021 bearing interest at 12% per annum. $ 34,000 $ — Convertible note agreement dated October 9, 2020 in the amount of $33,000 payable and due on October 9, 2021 bearing interest at 12% per annum. $ 33,000 $ — Convertible note agreement dated October 19, 2020 in the amount of $38.000 payable and due on October 19, 2020 bearing interest at 12% per annum. $ 38,000 $ — Convertible notes, net of discount $ 2,516.569 $ 2,475,341 The Company recognized $0 of debt discount accretion expense on the above notes. Interest expense related to these notes for the three months ended October 31, 2020 and 2019 was $100,457 and $92,016. Derivative liabilities Certain of the Company’s convertible notes are convertible into a variable number of shares of common stock for which there is not a floor to the number of common stock shares the Company might be required to issue. Based on the requirements of ASC 815 Derivatives and Hedging, the conversion feature represented an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results each reporting period. The Company uses the Black-Scholes option pricing model for the valuation of its derivative liabilities as further discussed below. There are no material differences between using the Black-Scholes option pricing model for these estimates as compared to the Binomial Lattice model. During the three months ended October 31, 2020, three new notes with a variable-rate conversion feature were issued. The Company valued the conversion features on the date of issuance resulting in initial liabilities totaling $548,944. Since the fair value of the derivative was in excess of the proceeds received, a full discount to the convertible notes payable and a day one loss on derivative liabilities of $452,944 was recorded during the three months ended October 31, 2020. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion prices ranging from $0.0029 to $0.0058, the closing stock price of the Company's common stock on the dates of valuation ranging from $0.008 to $0.034, an expected dividend yield of 0%, expected volatilities ranging from 219%-251%, risk-free interest rate ranging from 0.12% to 0.15%, and expected terms of one year. As of July 31, 2020, the Company had existing derivative liabilities of $205,796 related to two convertible notes. During the three months ended October 31, 2020, $97,772 in principle of these convertible notes along with fees of $13,000 were converted into 51,190,000 shares of common stock. At each conversion date, the Company recalculated the value of the derivative liability associated with the convertible note recording a gain (loss) in connection with the change in fair market value. In addition, the pro-rata portion of the derivative liability as compared to the portion of the convertible note converted was reclassed to additional paid-in capital. During the three months ended October 31, 2020, the Company recorded $525,430 to additional paid-in capital for the relief of the derivative liabilities. The derivative liabilities were revalued using the Black-Scholes option pricing model with the following assumptions: conversion prices ranging from $0.0018 to $0.007, the closing stock price of the Company's common stock on the dates of valuation ranging from $0.006 to $0.034, an expected dividend yield of 0%, expected volatility ranging from 215% to 262%, risk-free interest rates ranging from 0.12% to 0.15%, and expected terms ranging from 0.09 to 0.48 years. On October 31, 2020, the derivative liabilities on these convertible notes were revalued at $755,223 resulting in a loss of $525,913 for the three months ended October 31, 2020 related to the change in fair value of the derivative liabilities. The derivative liabilities were revalued using the Black-Scholes option pricing model with the following assumptions: conversion prices ranging from $0.0020 to $0.0029, the closing stock price of the Company's common stock on the date of valuation of $0.015, an expected dividend yield of 0%, expected volatility of 269%, risk-free interest rate of 0.13%, and an expected term ranging from 0.08 to 0.97 years. The Company amortizes the discounts over the term of the convertible promissory notes using the straight-line method which is similar to the effective interest method. During the three months ended October 31, 2020, the Company amortized $40,224 to interest expense. As of October 31, 2020, discounts of $122,363 remained for which will be amortized through October 2021.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Oct. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Office Lease Payments	Year Amount 2019-2020 $ 3,363 2020-2021 $ 22,737 2021-2022 $ 23,415 2022-2023 $ 24,122 2023-2024 $ 14,314

Organization and Description _2

Organization and Description of Business (Details Narrative) - USD ($)	Oct. 24, 2012	Nov. 16, 2017	Oct. 31, 2020	Jul. 31, 2020
Class of Stock [Line Items]
Preferred stock issued			10,000,000	8,000,000
Preferred stock issued, par value			$ 0.001	$ 0.001
Asset Management Company [Member]
Class of Stock [Line Items]
Sale of stock during period, Shares	55,000,000
Stock splits	2,200,000
Sale of stock during period, Value	$ 6,000
Merger [Member]
Class of Stock [Line Items]
Preferred stock issued		1,000,000
Preferred stock issued, par value		$ 0.001
Conversion rights of preferred stock issued		conversion and voting rights of 72.5 votes for each share, representing approximately 90.2% of the voting rights

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Oct. 31, 2020	Oct. 31, 2019
Accounting Policies [Abstract]
Allowance for doubtful accounts	$ 0	$ 0

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - USD ($)	Oct. 31, 2020	Jul. 31, 2020
Class of Stock [Line Items]
Derivative liabilities	$ 755,223	$ 205,796
Level 1
Class of Stock [Line Items]
Derivative liabilities
Level 2
Class of Stock [Line Items]
Derivative liabilities
Level 3
Class of Stock [Line Items]
Derivative liabilities	$ 755,223	$ 205,796

Going Concern (Details Narrativ

Going Concern (Details Narrative)	Oct. 31, 2020USD ($)
Going Concern [Abstract]
Accumulated deficit	$ (14,508,015)

Discontinued Operations - Liabi

Discontinued Operations - Liabilities of Discontinued Operations (Details) - USD ($)	Oct. 31, 2020	Jul. 31, 2020	Oct. 31, 2019
Accrued liabilities	$ 747,229	$ 607,961
Assets of Discontinued Operations
Accounts payable, net			$ 359,256
Rotal bank line of credit			16,515
Unearned revenue			152,181
Accrued liabilities	64,663		64,663
Custom duties and GST payable			54,296
HST	2,759		2,759
Liabilities of discontinued operations			$ 587,787

Discontinued Operations (Detail

Discontinued Operations (Details Narrativel) - USD ($)	Nov. 06, 2019	Oct. 31, 2020	Oct. 31, 2019
Accounting Policies [Abstract]
Sale of assets, value of assets sold	$ 54,296
Sale of assets, sale price	$ 10
Discontinued operations, including loss on disposal			$ (119,081)

Promissory Notes (Details)

Promissory Notes (Details) - USD ($)	Oct. 31, 2020	Jul. 31, 2020	Apr. 30, 2020	Oct. 31, 2019
Short-term Debt [Line Items]
Notes payable	$ 170,000	$ 170,000
Notes payable, total			$ 170,000	$ 170,000
Current portion long-term debt			170,000	170,000
Total long-term debt
Promissory Notes Five [Member]
Short-term Debt [Line Items]
Notes payable	30,000	30,000
Promissory Notes Six [Member]
Short-term Debt [Line Items]
Notes payable	135,000	135,000
Promissory Notes Seven [Member]
Short-term Debt [Line Items]
Notes payable	$ 5,000	$ 5,000

Promissory Notes (Details Narra

Promissory Notes (Details Narrative) - USD ($)	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Feb. 04, 2020	Jul. 18, 2018	Mar. 08, 2018
Short-term Debt [Line Items]
Interest Expense	$ 370,500	$ 428,500
Promissory Notes Five [Member]
Short-term Debt [Line Items]
Notes payable, issuance date	Mar. 8, 2018
Notes payable, maturity date	Mar. 8, 2019
Notes payable, rate of interest					10.00%
Promissory Notes Six [Member]
Short-term Debt [Line Items]
Notes payable, issuance date	Jul. 18, 2018
Notes payable, maturity date	Jul. 18, 2019
Notes payable, rate of interest				8.00%
Promissory Notes Seven [Member]
Short-term Debt [Line Items]
Notes payable, issuance date	Feb. 4, 2020
Notes payable, maturity date	Feb. 4, 2021
Notes payable, rate of interest			18.00%

Convertible Debt (Details)

Convertible Debt (Details) - USD ($)	Oct. 31, 2020	Jul. 31, 2020	Oct. 31, 2019	Feb. 20, 2018
Short-term Debt [Line Items]
Convertible notes				$ 1,034,000
Convertible notes, net of discount	$ 2,516,569		$ 2,475,341
Convertible Debt One[Member]
Short-term Debt [Line Items]
Convertible notes	11,041	$ 11,041
Convertible Debt Two [Member]
Short-term Debt [Line Items]
Convertible notes	1,034,000	1,034,000
Convertible Debt Three[Member]
Short-term Debt [Line Items]
Convertible notes	800,000	800,000
Convertible Debt Four [Member]
Short-term Debt [Line Items]
Convertible notes	300,000	300,000
Convertible Debt Five [Member]
Short-term Debt [Line Items]
Convertible notes	31,500	31,500
Convertible Debt Six [Member]
Short-term Debt [Line Items]
Convertible notes	3,800	3,800
Convertible Debt Seven [Member]
Short-term Debt [Line Items]
Convertible notes	36,500	36,500
Convertible Debt Eight [Member]
Short-term Debt [Line Items]
Convertible notes	95,000	95,000
Convertible Debt Nine [Member]
Short-term Debt [Line Items]
Convertible notes	15,000	15,000
Convertible Debt Ten [Member]
Short-term Debt [Line Items]
Convertible notes	47,500	47,500
Convertible Debt Eleven [Member]
Short-term Debt [Line Items]
Convertible notes	21,341	67,500
Convertible Debt Twelve [Member]
Short-term Debt [Line Items]
Convertible notes	15,887	31,500
Convertible Debt Thirteen [Member]
Short-term Debt [Line Items]
Convertible notes	34,000
Convertible Debt Fourteen [Member]
Short-term Debt [Line Items]
Convertible notes	33,000
Convertible Debt Fifteen [Member]
Short-term Debt [Line Items]
Convertible notes	$ 38,000

Convertible Debt (Details Narra

Convertible Debt (Details Narrative) - USD ($)

Oct. 09, 2020

Feb. 10, 2020

Dec. 04, 2019

Sep. 04, 2019

Aug. 06, 2019

Mar. 13, 2019

Oct. 19, 2020

Sep. 29, 2020

Apr. 15, 2020

Feb. 28, 2020

Feb. 21, 2020

Aug. 19, 2019

Jun. 28, 2019

Oct. 31, 2020

Oct. 31, 2019

Short-term Debt [Line Items]

Interest Expense

$ 100,457

$ 92,016

Debt discount accretion expense

0

Convertible Debt Two [Member]

Short-term Debt [Line Items]

Convertible debt

$ 1,034,000

Convertible note, rate of interest

10.00%

Convertible notes, conversion price

$ 0.028712

Convertible Debt Three[Member]

Short-term Debt [Line Items]

Convertible debt

$ 800,000

Convertible note, maturity date

Mar. 20, 2020

Convertible note, rate of interest

24.00%

Convertible Debt Four [Member]

Short-term Debt [Line Items]

Convertible debt

$ 300,000

Convertible note, maturity date

Jun. 28, 2020

Convertible note, rate of interest

20.00%

Convertible Debt Five [Member]

Short-term Debt [Line Items]

Convertible debt

$ 31,500

Convertible note, maturity date

Aug. 6, 2100

Convertible note, rate of interest

20.00%

Convertible Debt Six [Member]

Short-term Debt [Line Items]

Convertible debt

$ 3,800

Convertible note, maturity date

Aug. 19, 2020

Convertible note, rate of interest

24.00%

Convertible Debt Seven [Member]

Short-term Debt [Line Items]

Convertible debt

$ 36,500

Convertible note, maturity date

Sep. 4, 2020

Convertible note, rate of interest

20.00%

Convertible Debt Eight [Member]

Short-term Debt [Line Items]

Convertible debt

$ 95,000

Convertible note, maturity date

Dec. 4, 2020

Convertible note, rate of interest

12.00%

Convertible Debt Nine [Member]

Short-term Debt [Line Items]

Convertible debt

$ 15,000

Convertible note, maturity date

Feb. 10, 2021

Convertible note, rate of interest

12.00%

Convertible Debt Ten [Member]

Short-term Debt [Line Items]

Convertible debt

$ 47,500

Convertible note, maturity date

Feb. 21, 2021

Convertible note, rate of interest

12.00%

Convertible Debt Eleven [Member]

Short-term Debt [Line Items]

Convertible debt

$ 67,500

Convertible note, maturity date

Feb. 28, 2021

Convertible note, rate of interest

12.00%

Convertible Debt Twelve [Member]

Short-term Debt [Line Items]

Convertible debt

$ 95,000

Convertible note, maturity date

Apr. 15, 2021

Convertible note, rate of interest

10.00%

Convertible Debt Thirteen [Member]

Short-term Debt [Line Items]

Convertible debt

$ 34,000

Convertible note, maturity date

Sep. 29, 2021

Convertible note, rate of interest

12.00%

Convertible Debt Fourteen [Member]

Short-term Debt [Line Items]

Convertible debt

$ 33,000

Convertible note, maturity date

Oct. 9, 2021

Convertible note, rate of interest

12.00%

Convertible Debt Fifteen [Member]

Short-term Debt [Line Items]

Convertible debt

$ 38,000

Convertible note, maturity date

Oct. 19, 2021

Convertible note, rate of interest

12.00%

Convertible Debt One[Member]

Short-term Debt [Line Items]

Convertible debt

$ 30,000

Convertible note, rate of interest

12.00%

Convertible notes, conversion price

$ 0.002250

Convertible Debt - Derivative L

Convertible Debt - Derivative Liabilities (Details Narrative)	3 Months Ended
	Oct. 31, 2020USD ($)
Short-term Debt [Line Items]
Discounts	$ 122,363
Initial Valuation of Three Variable Notes
Short-term Debt [Line Items]
Liability of convertible note	548,944
Loss on derivative liability	$ 452,944
Valuation of conversion feature, details	The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion prices ranging from $0.0029 to $0.0058, the closing stock price of the Company's common stock on the dates of valuation ranging from $0.008 to $0.034, an expected dividend yield of 0%, expected volatilities ranging from 219%-251%, risk-free interest rate ranging from 0.12% to 0.15%, and expected terms of one year.
Amortized interest expense	$ 40,224
Initial Valuation of Two Variable Notes
Short-term Debt [Line Items]
Liability of convertible note	$ 205,796
Valuation of conversion feature, details	. The derivative liabilities were revalued using the Black-Scholes option pricing model with the following assumptions: conversion prices ranging from $0.0018 to $0.007, the closing stock price of the Company's common stock on the dates of valuation ranging from $0.006 to $0.034, an expected dividend yield of 0%, expected volatility ranging from 215% to 262%, risk-free interest rates ranging from 0.12% to 0.15%, and expected terms ranging from 0.09 to 0.48 years.
Subsequent Valuation of Two Variable Notes
Short-term Debt [Line Items]
Liability of convertible note	$ 755,223
Loss on derivative liability	$ 525,913
Valuation of conversion feature, details	conversion prices ranging from $0.0020 to $0.0029, the closing stock price of the Company's common stock on the date of valuation of $0.015, an expected dividend yield of 0%, expected volatility of 269%, risk-free interest rate of 0.13%, and an expected term ranging from 0.08 to 0.97 years.

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Feb. 20, 2018	Oct. 31, 2020	Oct. 31, 2019	Jul. 31, 2020
Shareholder advances as loan payable to related party		$ 0	$ 19,490
Due to Related Parties		386,404	375,344	$ 388,094
Professional Fees		82,884
Convertible notes	$ 1,034,000
Advances on note payable		$ 32,900
Convertible note, interest rate		10.00%
Interest expense		$ 21,759	26,062
Payments received		153,217
Advance on Note Payable
Advances on note payable	$ 175,000
Consulting
Professional Fees		$ 48,484	$ 44,769

Stockholders' Deficit (Details)

Stockholders' Deficit (Details)	May 15, 2019USD ($)shares	Nov. 01, 2017	Oct. 31, 2020$ / sharesshares	Jul. 31, 2020$ / sharesshares	May 06, 2020shares	Oct. 31, 2019shares	Apr. 29, 2019$ / sharesshares	Nov. 07, 2017$ / sharesshares
Common stock, shares authorized			500,000,000	250,000,000
Common stock, shares outstanding			158,789,105	105,099,277
Preferred Stock, Shares authorized			20,000,000	20,000,000
Preferred Stock, par value | $ / shares			$ 0.001	$ 0.001
Preferred shares issued and outstanding			10,000,000	8,000,000
Reverse stock split		On November 1, 2017, we effected a one-for- four reverse stock split. All share and per share information has been retroactively adjusted to reflect the stock split.
Reverse stock split ratio		0.25
Series C Preferred Stock
Preferred Stock, Shares authorized								1,000,000
Preferred Stock, par value | $ / shares								$ 0.001
Preferred shares issued and outstanding						1,000,000
Conversion rate			Each share of Series C Preferred Stock is convertible into 72.5 common shares and has voting rights based on this ratio.
Common stock, resulting from conversion	72,500,000
Series C Preferred Stock
Preferred shares converted to common stock | $	$ 1,000,000
Series D Preferred Stock
Preferred Stock, Shares authorized			10,000,000				10,000,000
Preferred Stock, par value | $ / shares			$ 0.001				$ 0.001
Preferred shares issued and outstanding						8,000,000
Conversion rate			Each share of Series D Preferred Stock is convertible into 72.5 common shares and has voting rights based on this ratio.
Regulation A Offering
Offering, amount of shares					43,000,000

Warrant (Details Narrative)

Warrant (Details Narrative) - USD ($)	Apr. 23, 2020	Apr. 15, 2020
Warrant 1
Convertible promissory note		$ 31,500
Conversion, shares		437,500
Conversion, price per share		$ 0.12
Common stock purchase warrant term		5 years
Warrant 2
Convertible promissory note	$ 75,000
Conversion, price per share	$ 0.15
Common stock purchase warrant term	3 years

Commitments and Contingecies (D

Commitments and Contingecies (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021	Oct. 31, 2020	Mar. 31, 2020
Accounting Policies [Abstract]
Future Lease Payments	$ 14,314	$ 24,122	$ 23,415	$ 22,737		$ 3,363
Weighted-average remaining lease term					2 years 9 months
Weighted-average discount rate					10.00%

Commitments and Contingecies _2

Commitments and Contingecies (Details Narrative)	3 Months Ended
	Oct. 31, 2020	Jun. 01, 2019
Accounting Policies [Abstract]
Facility site lease term	23 months
Expiration date of facility site lease	Dec. 31, 2020
Office space lease term	5 years
Expiration of office space lease term	Mar. 31, 2024
Additional office space lease term		5 years
Expiration of additional office space lease term	Mar. 31, 2024

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - $ / shares	1 Months Ended
	Dec. 04, 2020	Nov. 16, 2020	Nov. 23, 2020
Share Issuance 1
Stock issued for conversion of note payable		6,000,000
Stock issued for conversion of note payable, price per share		$ 0.0011
Share Issuance 2
Stock issued for conversion of note payable		8,000,000
Stock issued for conversion of note payable, price per share			$ 0.0018
Share Issuance 3
Stock issued for conversion of note payable	5,307,100
Stock issued for conversion of note payable, price per share	$ 0.0022